CSL Behring Plans $450M Expansion of Illinois, Australia Sites

Projects will add capacity to produce plasma intermediates in Kankakee, IL, site, and albumin in Melbourne
Flexsafe is based on a multilayer

Sartorius Stedim Biotech Introduces Novel Single-Use Bag Family

Sartorius' Flexsafe family allows single-use bioprocessing over the entire range of drug manufacture, from process development to production.

Scientists Find Flagellin-Expressing Cells Immunize Mice Against Cancer

Engineered tumor cells trigger T-cell responses that protect against subsequent tumor cell challenge.

Ring in the New: Rady Children’s Hospital Introduces NovaSeq for Newborn Diagnoses

In a talk at the ASHG annual conference, Stephen Kingsmore presented his vision for enhancing and expediting the pipeline.

Scientists Uncover Mdm2’s Role in Metastatic Breast Cancer

Study in JCI observed that TGF-beta-1 increased expression of the protein, which decreased p53 activity.
Cardiovascular disease is alleviated by an engineered protein

Stroke, Heart Attack Damage Could Be Mitigated via Mimicry of Good Cholesterol

Cardiovascular disease is alleviated by an engineered protein, a stable version of a chaperone protein found in good cholesterol, that helps suppress inflammation, lower blood pressure, and reverse tissue damage in mouse models

Novavax to Use Vivalis’ Duck Embryonic Stem Cell Line for Vaccine Production

Firm is developing VLP-based vaccines. Vivalis has granted Novavax the right to use its EB66® cell line for the production of VLP-based vaccines against several new potential viruses. The EB66 cell line is derived from...

ATMI Buys Partner Artelis to Acquire Disposable Bioreactor Platform and Expertise

Flagship iCELLis platform reportedly enables Phase III-scale production in laboratory-style facilities.

Novartis Cuts 300 Jobs, Names New CFO

Reporting its first-quarter financial results this week, Novartis announced a restructuring of its Lincoln, Nebraska manufacturing plant and its naming of a new CFO.

Orgenesis Acquires MaSTherCell

Buyer says deal will speed up development of lead product, AIPCs for type 1 diabetes, from pre-clinical testing into clinical trials

Recently Featured

Scroll Up